Forbes: Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds
Forbes, and a number of other publications, are reporting the results of a peer-reviewed research paper published in JAMA Network Open which states that vaccine protection against the omicron variant of covid-19 fades just weeks after second and third doses are administered.
Immunity against the omicron coronavirus variant fades rapidly after a second and third dose of Pfizer and BioNTech’s Covid-19 vaccine, according to peer reviewed research published in JAMA Network Open,,,
Levels of omicron-specific “neutralizing” antibodies—which can target the virus and stop it from replicating—decline rapidly after a second and third dose of Pfizer’s shot, according to the Danish study of 128 people who had received two or three doses.
Antibody levels, which are associated with protection against infection and disease, fell within weeks of getting the shots and were much lower than the level of antibodies specific to the original and delta coronavirus variants, the researchers said.